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The administration of digitalis g1ycosides causes a va-
riety of extracardiac effects. In both normal human sub-
jects and in other species, digitalis increases smooth mus-
cle tone of resistance and capacitance vessels. The
vasoconstriction is mediated, in part, by a direct action
of these glycosides on smooth muscle and, in part, by
an increase in alpha-adrenergic tone. Constriction of
coronary and splanchnic vesselsmay lead to myocardial
or mesenteric ischemia. In contrast to normal subjects,
patients with congestive heart failure demonstrate ar-
teriolar and venodilation in response to these glycosides,
possibly because the myocardial effect, to increase car-
diac output and peripheral blood flow, overcomes the
vasoconstrictor properties of these drugs. Other impor-
tant actions of digitalis glycosides occur in the central
William Withering (1) described both the therapeutic use-
fulness and certain side effects of extracts of the foxglove
in 1785. He noted an improvement in the pulse quality.
Since that time, investigators have demonstrated that digi-
talis glycosides can increase myocardial contractility and
alter the electrical activity of the myocardium. More re-
cently, cardioactive glycosides have been shown to have
important effects on vascular and visceral smooth muscle,
as well as on the central and peripheral nervous systems. It
is the purpose of this review to discuss the extracardiac
effects of digitalis, particularly with reference to the pe-
ripheral vascular system, including the coronary and
splanchnic circulations, as well as their effects on gastroin-
testinal smooth muscle, the kidney, the central nervous sys-
tem and afferent nerve endings from arterial baroreceptor
and cardiac regions.
Peripheral Circulation
Studies in Experimental Animals
Arterioles. The intraarterial or intravenous injection of
ouabain in anesthetized pigs, rabbits and dogs causes local
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and peripheral nervous systems. Their effectson the area
postrema of the medulla oblongata are largely respon-
sible for the a1pha-adrenergic-mediated peripheral va-
soconstriction, as well as the nausea and vomiting that
frequently accompany digitalis intoxication. Actions of
glycosides on the cerebral cortex are responsible for the
wide range of neurotoxic effects that range from visual
disturbances and headaches to seizures and coma. Fi-
nally, peripheral neurologic effectsof digitalis glycosides
on baroreceptor and cardiac alTerent fibers may: 1) im-
prove the depressed function of these receptors in the
situation of heart failure, and 2) reflexlylower peripheral
vascular resistance, thereby partially preventing the vas-
cular constrictor action of these glycosides.
(J Am Coli CardioI198S;S:99A-lOSA)
vasoconstriction and an increase in total peripheral vascular
resistance (2-5). Differences between various cardiac gly-
cosides appear to exist, because digoxin does not alter sys-
tolic blood pressure or systemic vascular resistance (4).
Acetylstrophanthidin administered to conscious dogs causes
an increase in myocardial contractility but does not alter
systemic or pulmonary vascular resistance (6-8). However,
ouabain causes a nonuniform regional circulatory effect in
the conscious dog (9). For instance, there is an initial va-
soconstriction followed by a more prolonged vasodilation
in the mesenteric vascular bed and a prolonged constriction
in the renal and iliac circulations. Although normotensive
dogs respond to intravenous digoxin with sustained vaso-
constriction, animals made hypotensive by hemorrhage de-
velop a short-lived vasoconstriction followed by a more
prolonged period of vasodilation (10). The mechanism of
the vasoconstriction is alpha-adrenergic, whereas the va-
sodilation in hypotensive animals is cholinergic.
Studies on the regional circulatory response to digitalis
glycosides have revealed an alpha-adrenergic vasoconstric-
tor component in the hindlimb, skeletal muscle and mes-
enteric circulations (10-14). In contrast to the action of other
vasoconstrictor agents, such as catacholamines, angiotensin
II, prostaglandin Fza, dopamine and vasopressin, digoxin
infused into the mesenteric artery of dogs decreases blood
flow and reduces oxygen consumption of the gut (14). Ox-
ygen consumption is reduced because the small increase in
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arteriovenous oxygen extraction does not fully compensate
for the reduced blood flow. Other studies have shown that
mesenteric vascular resistance increases after the adminis-
tration of digoxin in dogs that have a proximal mesenteric
artery stenosis (12).
Thus, although there is some variation in the effect of
different cardiac glycosides, most compounds cause arter-
iolar vasoconstriction in normotensive animals. This effect
is observed in the skeletal muscle and splanchnic circula-
tions. This increase in smooth muscle tone is mediated, in
part, by an increase in alpha-adrenergic stimulation and, in
part, by direct effects on vascular smooth muscle as dis-
cussed subsequently.
Veins. Tainter and Dock (15) and Rodman and Pastor
(16) suggested that venous pooling occurred in the splanch-
nic circulation after the administration of cardiac glycosides.
Later studies using high doses of acetylstrophanthidin, an
aglycone, showed that in the dog this pooling was associated
with an increase in portal vein pressure (5,17-19). How-
ever, a more recent examination of the capacitance vessels
in dogs has shown that ouabain actually decreases total
peripheral vascular capacity, characterized by a reduction
in splanchnic and extrasplanchnic blood volumes (20). The
decrease in splanchnic blood volume occurs despite an in-
crease in transhepatic resistance. Although alpha-adrenergic
blockade prevents the increase in transhepatic resistance, it
does not reduce the generalized venoconstriction. This ob-
servation suggests that the effect of digitalis on total vascular
capacity is mediated by a direct action on vascular smooth
muscle. Thus, ouabain causes constriction of splanchnic and
extrasplanchnic capacitance vessels of the dog. However,
acetylstrophanthidin administration increases transhepatic
venous resistance, an action which may overcome the
splanchnic constriction and lead to pooling of blood in this
circulation.
Studies in Patients
Arterioles and veins. The finding of arteriolar constric-
tion in animals has been confirmed in patients undergoing
open heart surgery during constant perfusion of the systemic
circulation (21). Thus, both acetylstrophanthidin and lan-
atoside-C increase systemic vascular resistance by an av-
erage of 23%. The change in arteriolar resistance is of earlier
onset and shorter duration than the inotropic action of dig-
italis glycosides. Ouabain induces both direct arteriolar and
venoconstriction in the forearm of normal subjects (22). In
contrast, patients with congestive heart failure demonstrate
both venodilation and arteriolar dilation in response to oua-
bain (22). Although the mechanism for the digitalis-induced
vasodilation is not entirely understood, it may stem from
the observation that there is a high arteriolar and venous
tone at rest consequent to increased neurohumoral activity
present in heart failure (23). Thus, the improved cardiac
output and peripheral blood flow consequent to the effect
of digitalis on the myocardium lowers sympathetic tone.
The reduction in sympathetic tone presumably is greater
than the direct vasoconstrictor action of digitalis, and there-
fore leads to a net decrease in arteriolar and venous vascular
resistance. Another possible explanation for the observed
vasodilation is that digitalis may either stimulate or sensitize
arterial baroreceptor and cardiac afferents to reflexly lower
peripheral vascular resistance (see following for detailed
explanation).
Mesenteric circulation. Digoxin administration has been
found to reduce splanchnic blood volume in subjects without
heart disease (24,25). The fact that rapid digitalization oc-
casionally leads to the development of acute pulmonary
edema in some patients with heart disease is thought to be
secondary either to: 1) the peripheral arteriolar vasocon-
strictor effect of this drug, which becomes manifest before
its positive inotropic action, or 2) a translocation of blood
volume from the splanchnic to the pulmonary circulation
(26,27). It is likely that the extracardiac arteriolar effects
of digitalis in human beings prevent an increase in cardiac
output in healthy patients, despite an increase in myocardial
contractility.
Digitalis administration has been associated with mes-
enteric infarction, which, in some instances, results in fatal
hemorrhagic necrosis ofthe gut (28,29). In this regard, long-
term administration of digitalis glycosides has been asso-
ciated with chronic ischemia of the gut (29,30). Addition-
ally, malabsorption syndromes have been found in some
patients with congestive heart failure who are being treated
with digitalis glycosides (31,32). These mesenteric syn-
dromes may result from the arteriolar vasoconstrictioncaused
by the cardiac glycosides that has been amply demonstrated
in animal preparations, as described previously.
Coronary Circulation
Ouabain causes a short duration «30 minutes) constric-
tion of coronary arteries in anesthetized dogs (33,34), healthy
human subjects (35,36) and patients with coronary artery
disease (37). The increase in coronary vascular resistance
can be prevented if ouabain is injected slowly over a 2
minute period rather than rapidly over a 10 second period
(35). Coronary flow at rest is reduced and coronary vascular
resistance is increased in patients with coronary disease after
a 5 minute infusion of 1 mg of digoxin (38). The human
myocardium has been shown to produce lactate and, in
certain circumstances, an increase in left ventricular end-
diastolic pressure occurs after rapid infusion of ouabain (15
jLg/kg body weight) (35). This observation has been con-
firmed in dogs that, under the condition of global myocardial
ischemia, may develop an alpha-adrenergic-mediated in-
crease in coronary vascular resistance, an increased left
ventricular end-diastolic pressure and subsequent ventricular
fibrillation after injection of 0.5 mg of acetylstrophanthidin
(39). These effects are thought to represent an increase in
myocardial ischemia.
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Investigators have speculated that the increase in myo-
cardial ischemia associated with digoxin administration in
the presence of a small infarction is consequent to an aug-
mentation of myocardial oxygen demands (40). On the other
hand, it is possible that the coronary vasoconstrictor effect
of digitalis glycosides leads to a worsening of ischemia with
subsequent deterioration of myocardial performance (35,39).
However, in most patients with coronary artery disease
without heart failure, the effect of a slow infusion of a
digitalis glycoside on myocardial ischemia is thought to
represent a trade off between the decrease in end-diastolic
volume versus the increased contractile state and associated
increase in afterload with little effect on coronary vascular
resistance (36,38,41). In the presence of congestive heart
failure, the decrease in end-diastolic volume and improved
contractility serve to reduce wall tension and myocardial
oxygen consumption, thereby offsetting the effect of the
increased contractile state, which augments myocardial ox-
ygen consumption.
Smooth Muscle of the Gastrointestinal Tract
Some of the more debilitating side effects associated with
digitalis are nausea, vomiting and diarrhea (42). The digi-
talis glycosides have been demonstrated by radiographic
techniques to increase visceral smooth muscle tone and de-
crease the transit time through the gastrointestinal tract (43).
These effects on visceral smooth muscle have been dem-
onstrated to occur in several other organs, including the
isolated uterus, vas deferens, bronchial smooth muscle and
gallbladder, after exposure to digitalis glycosides (44). With
respect to the gastrointestinal tract, there appears to be an
order of sensitivity with the rectum being most sensitive,
teniae coli of the colon somewhat less sensitive, the ileum
still less sensitive and gastric strips the least sensitive (45).
The Kidney
Cardiac glycosides produce diuresis and natriuresis through
a direct action on the kidney (46-50). In part, the natriuretic
effect may be mediated through inhibition of sodium reab-
sorption in the distal nephron (51). The natriuretic effect of
ouabain varies depending on the intrarenal distribution of
filtered sodium at the time of the experiments (52). The
diuretic action of digitalis glycosides is dependent on its
effect on the membrane adenosine triphosphate (ATPase)
system (53,54).
The Endocrine System
Long-term therapy with digitalis can cause gynecomastia
in men and breast enlargement in women (55-57). This side
effect can be accompanied by pain. It is associated with an
elevation in the serum estrogen level and a decrease in serum
leuteinizing hormone and plasma testosterone (58). Also, it
has been suggested that the structural similarity between
digitalis glycosides, their metabolites and estrogen causes
this disturbing side effect (59).
Mechanisms Underlying the Extracardiac
and Toxic Actions of Digitalis
There appear to be several important mechanisms through
which digitalis glycosides exert their extracardiac effects.
These include: I) a direct smooth muscle action, 2) an
indirect effect on smooth muscle mediated by direct stim-
ulation of the central nervous system to increase alpha-
adrenergic tone, and 3) an indirect effect caused by reflex
stimulationof baroreceptor and cardiac afferent nerve endings.
Direct smooth muscle effects of digitalis. Many of the
cardiovascular, circulatory and gastrointestinal effects of
digitalis appear to be caused by a direct action on smooth
muscle. For instance, isolated human crural arteries and
veins develop long-lasting contractions in the presence of
digoxin (60). These contractions are not diminished by al-
pha-adrenergic blockade but can be abolished by the calcium
entry antagonist, nifedipine. The contractile response of
aortic strips to electrical stimulation can be potentiated with
ouabain (61). Furthermore, the contraction caused by nor-
epinephrine is potentiated by ouabain (61).
Potentially, there are three mechanisms by which the
digitalis glycosides may increase smooth muscle tone. All
three mechanisms lead to an increase in intracellular calcium
concentration and, therefore, contraction of the smooth mus-
cle cells. The first mechanism is an inhibition of the
Na + -K + ATPase pump. This leads to an increase in the
intracellular sodium concentration, which then leads to de-
creased calcium efflux through a sodium-calcium exchange
mechanism (62). A second potential mechanism is an in-
hibition of the electrogenic Na + -K + pump in vascular smooth
muscle, which leads to a slight depolarization of the smooth
muscle fibers, thereby increasing calcium conductance across
the cell wall or releasing stored calcium from inside the cell
or from the cell wall (63-65). A third mechanism that has
been suggested is a Na + -K + ATPase-dependent pump which,
when inhibited, causes the release of catecholamines that,
in tum, induce contraction of the vascular smooth muscle
(66,67).
Currently, there is information suggesting that both of
the first two mechanisms, that is, inhibition of the Na + -K +
ATPase pump and an electrogenic pump effect, may mediate
the increase in vascular tone after the administration of
digitalis glycosides (68,69). However, the third mechanism,
that is, local release of catecholamines stimulated by the
glycosides, appears unlikely to playa major role because
prior depletion of catecholamines with reserpine or dener-
vation does not alter the effect of ouabain (70,71).
Central nervous system effects of digitalis glyco-
sides. Abundant evidence is available demonstrating that
digitalis glycosides exert part of their extracardiac effects
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through an action on the central nervous system (70). For
instance, the alpha-adrenergic-mediated increase in coro-
nary vascular resistance caused by highly polar cardiac gly-
cosides can be abolished by brainstem transection 2 mm
below the obex (71). Such information suggests that the
cardiac glycosides ihcrease alpha-adrenergic tone by stim-
ulating the area postrema of the medulla, a region that is
devoid of a blood-brain barrier (71). This is the same region
that is thought to be responsible, in part, for the arrhythmias,
nausea and vomiting that can occur after the intravenous
injection of a cardiac glycoside (72-75).
In 1785, Withering (I) described several symptoms of
digitalis intoxication resulting from large and repeated doses
of foxglove. These included "sickness, vomiting, purging,
giddiness, confused vision, objects appearing green or yel-
low. . . ." Other complications of digitalis intoxication in-
clude weakness, headache, fatigue, nocturnal confusion,
disorientation, nightmares, delusions, hallucinations, acute
mania or depression, paresthesias, neuralgias, and myalgias
(59,76-81). Up to 20% of patients receiving digoxin became
intoxicated (82). In one study (83) of an epidemic of digitalis
intoxication caused by a packaging error, 95% ofthe patients
had fatigue, 95% visual complaints, 82% muscular weak-
ness, 80% nausea, 80% anorexia, 65% psychiatric distur-
bances, 65% abdominal pain, 59% dizziness, 54% dreams,
45% headache, 41% diarrhea, 40% vomiting and 9% chest
pain. Visual symptoms described are blurring, dimness,
scotoma, flickering or flashing lights of yellow, green or
red colors, cycloplegia, amblyopia, diplopia and blindness;
they occur in II to 95% of patients, particularly in cases
of digitoxin intoxication (79,83-86).
Many of these toxic effects of digitalis glycosides prob-
ably result from their profound excitatory effects on nerve
cells. These compounds exert a disorganizing influence on
the central nervous system and enhance neural activity, in
part by lowering the nerve membrane threshold for depo-
larization. (87). For instance, ouabain and strophanthidin
injected intravenously or applied topically to the brain de-
crease the seizure threshold and increase duration of seizures
evoked by electrical stimulation of the sensory cortex (88).
Perfusion of the lateral ventricles of the cat with ouabain
causes a large dose-dependent release of 5-hydroxytrypt-
amine (5-HT) which can be blocked by 5-HT-specific an-
tagonists (89). This has led to the speculation that 5-HT
plays amajor role in the genesis of cardiac-glycoside-related
neurotoxicity. Other studies have suggested that these com-
pounds increase the central nervous system dopamine con-
tent and that this action may be related to their toxic effects
(90).
Thus, many of the toxic actions of digitalis glycosides
are caused by their effects on cortical and medullary regions
of the central nervous system. These effects may be me-
diated by an alteration in one or more of the neurotrans-
mitters. However, further work is necessary to establish the
exact mechanism of action of cardiac glycosides on the
central nervous system.
Effects of digitalis glycosides on baroreceptor and car-
diac afferent nerve endings. Digitalis glycosides have an
interaction with the afferent endings located in the carotid
sinus region as well as those innervating the heart (91-96).
For instance, digitalis increases the discharge rate of afferent
nerve fibers located in the carotid sinus nerve (92,93). Both
chemoreceptor and baroreceptor afferents are located in this
nerve. In addition, the electrical activity of vagal afferent
fibers innervating the myocardium is increased by digitalis
glycosides (95). Because stimulation of any of these affer-
ents generally causes reflex cardiovascular depression, one
might speculate that the direct vascular and central nervous
system-mediated vasoconstrictor effects, in part, are limited
by these reflexes. Alternatively, the arteriolar vasodilation
observed after administration of cardiac glycosides to pa-
tients with congestive heart failure may occur, in part, through
their effects on baroreceptor and cardiac afferent nerve end-
ings (21). Investigators also have speculated that the pooling
of blood in splanchnic veins leads to a decrease in venous
return, a beneficial effect that could be ascribed to a reflex
action of these cardiac glycosides (5,20). Finally, activation
of cardiac receptors has been associated with a reduction in
the secretion of antidiuretic hormone (97). Thus, stimulation
of these receptors by cardiac glycosides could decrease the
secretion of antidiuretic hormone and increase the excretion
of both sodium and free water (98).
Patients with congestive heart failure demonstrate a re-
duced discharge activity ofvagal afferent nerves innervating
the heart (98-101). Because the digitalis glycosides sen-
sitize these receptors to discharge more vigorously to stimuli
such as elevations of left atrial pressure, these drugs may be
important in restoring a more normal neurohumoral state in
such patients (95,102). In addition, by reducing the circu-
lating level of plasma antidiuretic hormone, these drugs may
partially restore the renal function in patients with conges-
tive heart failure. Therefore, in addition to the important
inotropic effects of cardiac glycosides, these drugs may
improve the clinical condition of patients with heart failure
by stimulating baroreceptor and cardiac afferent nerves to
reduce the excessive vasoconstriction in resistance and ca-
pacitance vessels and to enhance excretion of salt and free
water.
Conclusions
Digitalis glycosides have a plethora of cardiac and ex-
tracardiac effects. Although some of the extracardiac ef-
fects, such as nausea, vomiting, abdominal pain, malab-
sorption syndromes, gynecomastia and central nervous system
symptoms can be very disturbing to patients, these drugs
generally appear to improve cardiovascular function. Car-
diac glycosides exert important arteriolar and venoconstric-
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tor effects in patients without congestive heart failure. The
origin of these effects is mediated through a direct action
of glycosides on vascular smooth muscle and an indirect
action caused by stimulation of the medullary brainstern
centers. An important but less well studied mechanism of
action appears to involve reflexes originating in the heart
and baroreceptor regions. In normal subjects these reflexes
may reduce the direct peripheral vasoconstrictor response,
but in patients with heart failure, these reflexes probably
assist in restoring the cardiovascular homeostasis by pro-
moting a diuresis, reducing the exaggerated neurohumoral
discharge and possibly transiently reducing venous return,
which in turn reduces the degree of pulmonary congestion.
Thus, although Withering described the therapeutic useful-
ness of foxglove extracts 200 years ago, only recently have
we come to appreciate some of the more diverse and im-
portant extracardiac manifestations of this drug.
We thank Rita Stempler for secretarial assistance.
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